An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
Part of paid clinical trials in Tamarac, Florida.
- Sponsor
- Hoffmann-La Roche
- Study ID
- NCT07620392
- Phase
- PHASE2
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Afimkibart — DRUGParticipants will receive Afimkibart as per the schedule mentioned in the protocol.
Study Details
The study will evaluate the long-term safety and efficacy of Afimkibart (also known as RO7790121) in participants with moderate to severe Rheumatoid Arthritis (RA) who have an inadequate response or intolerance to tumor necrosis factor (TNF) and/or Janus kinase (JAK) inhibitors, and who were previously treated with Afimkibart.
Key Dates
- First listed
- Jun 2, 2026
- Start date
- Jun 3, 2026
- Status verified
- Jul 2026
- Primary completion
- Jul 8, 2033
- Completion
- Jul 8, 2033
Study Design
- Enrollment
- 120 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Afimkibart Group IParticipants will recieve Afimkibart as subcutaneous (SC) injection.
- Experimental: Afimkibart Group IIParticipants will receive Afimkibart as SC injection.
Primary Outcome Measure
Percentage of Participants With Adverse Events (AEs) [ Time Frame: From Baseline up to 6 years ]
Central Contacts
- Reference Study ID Number: WA46440 https://forpatients.roche.com/ No attachments to email below.888-662-6728
- Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| West Broward Rheumatology Associates, Inc. | Tamarac | Florida | 33321 | - |
| Accurate Clinical Management LLC | Houston | Texas | 77089 | - |
| DM Clinical Research | Tomball | Texas | 77375 | - |
Find similar trials in Tamarac, FL
Nationwide
By condition
Related Studies
- Physica System Total Knee Replacement Registry StudyRecruiting · Limacorporate S.p.a · Rancho Mirage, California
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Sacramento, California
- RA-PRO PRAGMATIC TRIALPHASE3 · Recruiting · University of Alabama at Birmingham · Auburn, Alabama
- Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint InhibitorsRecruiting · M.D. Anderson Cancer Center · Houston, Texas